Han M, Potter S R, Partin A W
Department of Urology, James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Marburg 1, 600 North Wolfe Street, Baltimore, MD 21287, USA.
Curr Urol Rep. 2000 May;1(1):78-82. doi: 10.1007/s11934-000-0039-8.
Prostate-specific antigen (PSA) is the most important serum tumor marker for prostate cancer detection. Free PSA is one of the many molecular forms of PSA that have been identified. Percent free PSA improves the specificity (elimination of unnecessary biopsies) for prostate cancer detection in men with nonsuspicious digital prostate examination and total serum PSA ranges between 4 and 10 ng/mL. Further study is necessary to determine the optimal clinical utility of percent free PSA in men with a total serum PSA level of less than 4 ng/mL. In addition, the level of free PSA may be affected by many factors, including age, prostate volume, prostate manipulation, sample handling, and type of assay used.
前列腺特异性抗原(PSA)是用于前列腺癌检测的最重要的血清肿瘤标志物。游离PSA是已被鉴定出的PSA的多种分子形式之一。对于直肠指检无异常且总血清PSA在4至10 ng/mL之间的男性,游离PSA百分比可提高前列腺癌检测的特异性(避免不必要的活检)。对于总血清PSA水平低于4 ng/mL的男性,有必要进一步研究以确定游离PSA百分比的最佳临床应用价值。此外,游离PSA水平可能受多种因素影响,包括年龄、前列腺体积、前列腺操作、样本处理及所采用的检测方法类型。